Defense Dept. Funds Ketamine Study For PTSD Treatment In 600 Service Members & Veterans
A Department of Defense (DOD) Health Agency-funded adaptive platform trial for alternative treatments for PTSD will test SLS-002 on some 600 active-duty service members and veterans.
